Abstract
Inhibition of the checkpoint protein CTLA-4 by the US-FDA's approved monoclonal antibody ipilimumab has delivered breakthrough therapies against a wid......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
